This guide covers the basics on brainstem tumors, including symptoms, tests, treatment options and what affects prognosis for slow- and fast-growing tumors.
Update Date: 06.02.2026
A brainstem tumor is a growth in the midbrain, pons or medulla. These three areas connect the brain to the spinal cord and guide many essential functions.
Most brainstem tumors are gliomas. These include diffuse midline glioma and low-grade glioma in children. These tumors often grow along the brainstem's busy nerve pathways, which makes them hard to separate from nearby tissue.
In adults, brainstem tumors are less common and include a broader mix of gliomas and other tumors.
Even small tumors can cause significant issues. Because the brainstem is small and tightly packed, a brainstem tumor can affect movement, balance, coordination, sensation, speech or basic body functions. Some tumors grow slowly in one area while others spread more widely through nearby tissue. A tumor may appear as a single mass or as multiple spots.
Brainstem tumors can be noncancerous, also called benign. Or they can be cancerous, also called malignant. Even slow-growing tumors may be hard to remove because they sit close to nerves and nervous system pathways that guide movement, breathing, swallowing and other important functions. Whether a brainstem tumor can be removed depends on the tumor's type, how it grows and how closely it touches these critical structures.
Brainstem tumors can begin in different kinds of cells. Most start in glial cells, which support nerve cells. These growths are called gliomas, and they are the most common type of brainstem tumor.
Gliomas include several subtypes that start in different parts of the brainstem and grow in different ways.
Diffuse midline glioma (DMG) is a common type of brainstem tumor. Diffuse midline gliomas are especially common in children, where they make up most malignant brainstem tumors. Historically, in children these tumors were referred to as diffuse intrinsic pontine gliomas (DIPGs). These high-grade gliomas grow quickly and usually begin in a part of the brainstem called the pons. They spread between cells in the brainstem rather than forming clear borders, which makes them difficult to remove with surgery.
Low-grade glioma grows more slowly and may stay in one place. Some low-grade gliomas grow outward from the brainstem surface. They are called exophytic tumors and can sometimes be easier to reach with surgery. Subtypes of low-grade gliomas found in the brainstem include:
Ganglioglioma — a rare tumor that contains both nerve cells and glial cells and may develop in the lower brainstem.
These tumors can appear in any part of the brainstem, including the midbrain or medulla.
There are other rare types of gliomas that can occur. Angiocentric gliomas are linked to changes in the MYB gene.
Polymorphous low-grade neuroepithelial tumors of the young (PLNTYs) are linked to changes in genes that affect the MAPK pathway, such as BRAF or FGFR.
Many childhood-type diffuse low-grade gliomas have gene changes that affect the MAPK pathway. Adult-type diffuse low-grade gliomas usually have changes in the IDH gene.
Other rare tumors can form in the brainstem, although they are much less common than gliomas. These may occur in different parts of the brainstem or other parts of the brain. They are seen more often in adults. Some of these rare tumors include ependymomas and hemangioblastomas.
Brainstem tumor symptoms can affect movement, balance, coordination, eye motion, facial control, breathing and swallowing. Because the brainstem is very compact and carries many message routes between the brain and body, people often notice several symptoms at once.
Symptoms can build over time or appear more quickly. Some tumors grow in a way that causes steady changes that get worse little by little. Others grow more slowly, which can lead to symptoms that develop over weeks or even months.
Common symptoms for brainstem tumors include:
You should seek care if you notice new symptoms that affect movement, balance, eye motion, speech, swallowing or strength. These symptoms can appear suddenly or build over time and may be a sign that changes in the brainstem are affecting how signals travel between the brain and body.
Seek care right away for symptoms such as:
You also should seek care if symptoms keep getting worse over days or weeks or if new symptoms appear. Even mild changes can be important when they involve the brainstem.
The exact cause of most brainstem tumors is not known. In many cases, a tumor forms when certain cells in the midbrain, pons or medulla begin to grow in an uncontrolled way. Most brainstem tumors start in glial cells, which support communication between nerve cells. Changes within these glial cells can lead to gliomas, the most common type of brainstem tumor.
Researchers have found that some gliomas develop because of gene changes that affect how glial cells grow and divide. These gene changes can happen on their own during cell development and are not usually linked to anything a person did or was exposed to.
For most people, there is no clear cause or trigger for a brainstem tumor. There is no evidence that diet, stress or environmental exposures cause brainstem tumors. Current research continues to study how gene changes and cell growth patterns contribute to these tumors.
There are very few known risk factors for brainstem tumors. For most children and adults, a brainstem tumor happens without any identifiable risk factor. The most well-known risk factor is having had a high dose of radiation earlier in life, for example, as treatment for other tumors or cancers.
There are no known links between brainstem tumors and lifestyle habits, environmental exposures or personal choices.
Brainstem tumors are more common in children than adults. Gliomas that begin in the pons occur most often in children.
A small number of people with inherited conditions, such as neurofibromatosis type 1 (NF-1), have a higher chance of developing certain brainstem tumors including pilocytic astrocytomas. Even in these conditions, brainstem tumors are still uncommon.
A brainstem tumor can lead to complications when its growth blocks nearby spaces. The tumor can interfere with breathing, swallowing, fluid flow or long-term nerve function.
Possible complications include:
These complications reflect the long-term effects a brainstem tumor can have on movement, breathing and other functions. Complications can be different from person to person, but many occur because the brainstem is small and controls many important body functions.
There is no known way to prevent a brainstem tumor. These tumors form when certain cells in the midbrain, pons or medulla begin to grow in an uncontrolled way. Most tumors start because of gene changes inside glial cells. These changes often happen on their own and are not linked to diet, lifestyle or environmental exposures.
Diagnosing a brainstem tumor begins with learning about symptoms and doing a physical exam. A neurological exam is used to check balance, eye motion, strength, coordination and swallowing. These findings help the care team understand which parts of the brainstem may be affected.
Imaging tests are then used to look closely at the brainstem. In some cases, a small sample of tissue or cerebrospinal fluid may be taken to learn more about the tumor's cells to establish a diagnosis.
Magnetic resonance imaging (MRI). A brain MRI is the main test used to diagnose a brainstem tumor. It creates detailed pictures of the brainstem and can show whether a growth is present, where it is located, and how it affects nearby structures. MRI scans can show features that help identify:
MRI with and without contrast can help identify common tumor types, including diffuse midline glioma (DMG) and other gliomas that can form in the brainstem.
MRI also can show whether the tumor stays in one area or spreads through brainstem tissue, which helps guide the next steps in diagnosis.
A mass that shows on brainstem MRI means there is an area that looks different from the surrounding tissue. This may be a tumor or another type of lesion. MRI helps show the size and position of the mass and how it affects nearby areas.
Some changes seen on brainstem MRI scans may be caused by conditions other than a tumor, such as inflammation, cavernous malformations, or other types of lesions including inflammatory or demyelinating conditions such as multiple sclerosis. Imaging tests help the care team understand the cause and guide other testing.
Other imaging. Depending on the situation, the care team may use additional imaging to better understand the growth or to rule out other conditions. These may include brain CT scans or specialized MRI techniques. These tests help confirm the tumor's position and its effect on surrounding areas.
In some cases, a small sample of tissue is taken with a needle to study the tumor's cells. This is called a needle biopsy. Modern techniques allow biopsies to be performed with high accuracy and a low rate of lasting side effects.
A biopsy is most helpful when MRI results are unclear or when several tumor types are possible based on imaging alone.
In some situations, a lumbar puncture may be done to look at the spinal fluid for clues about the tumor. The fluid can be checked for cells that have moved from the tumor or for genetic changes that point to a certain type of tumor. This information can help confirm what type of tumor you have and help the care team plan next steps.
After imaging and biopsy results are collected, the care team looks at the tumor's location, its pattern of growth and the features of the cells. These details help identify the tumor type and guide decisions in later steps of care.
Treatment for a brainstem tumor depends on the tumor's type, size and location. The main treatments for brainstem tumors include:
The goal of cancer treatment is to manage the tumor's growth and to help protect movement, breathing, swallowing and other functions guided by the brainstem.
Surgery. Brain tumor surgery may be used when a tumor is in a spot that can be reached safely. This is more common with tumors that grow in one area, such as some low-grade gliomas. Growths that reach open fluid-filled spaces around the brainstem can sometimes be easier to remove.
Many brainstem tumors cannot be fully removed because they grow near areas that control important functions such as movement, breathing and swallowing. In these cases, surgery may be limited to removing part of the growth or reducing pressure in nearby spaces.
Clinical trials are research studies that test new ways to find, treat or understand brainstem tumors. These studies are important because many brainstem tumors, especially diffuse midline gliomas, are difficult to treat with current options.
Researchers are studying treatments that act on gene changes found in some low-grade gliomas and diffuse midline gliomas. These studies may look at medicines that act on growth signals inside the tumor or medicines matched to specific gene changes, including the BRAF gene.
Some studies are testing medicines that block signals inside tumor cells that tell them to grow. Early research shows these medicines may slow growth in some low-grade gliomas, but more studies are needed to understand how well they work in brainstem tumors.
Other trials are testing new ways to deliver medicine directly to the brainstem. These approaches aim to reach the tumor more effectively while limiting effects on nearby areas that guide movement, breathing and swallowing.
Trials also are studying new imaging tools, biopsy methods and supportive treatments. These studies help the care team understand how brainstem tumors grow and how they respond to different therapies.
Ongoing research continues to explore the genetic and molecular features of brainstem tumors to guide new treatment options.
The outlook for a brainstem tumor depends greatly on the tumor's type, where it is located and how it grows. Some tumors grow slowly and may stay in one area for a long time. Others grow quickly and are harder to control because they spread through brainstem tissue.
Life expectancy also varies based on these factors. There is no single cure for all brainstem tumors, and outcomes depend on how the tumor behaves over time.
Tumors such as diffuse midline glioma tend to grow quickly and are harder to control. These tumors often spread through the pons and surrounding areas, which limits the options for removing or slowing the growth. This pattern can lead to a shorter survival.
Low-grade gliomas usually grow more slowly. These tumors may stay in one spot and can sometimes be managed for long periods with treatment or observation. Pilocytic astrocytoma, pilomyxoid astrocytoma, fibrillary astrocytoma and ganglioglioma belong to this group.
The tumor's size and position in the midbrain, pons or medulla can affect the outlook because these areas guide important body functions. Age also plays a role. Children are more likely to have tumors that begin in the pons, while adults have a wider mix of tumor positions.
Prognosis is different for each person. But understanding the type of brainstem tumor and how it grows is an important first step in planning care.
If you have symptoms that worry you, make an appointment with a doctor or other healthcare professional. If you have a brainstem tumor, you'll likely be referred to specialists, such as:
Here's some information to help you get ready for your appointment.
Questions to ask at your first appointment include:
Questions to ask an oncologist or a neurologist include:
In addition to the questions that you've prepared, don't hesitate to ask any other questions that may come up during your appointment.
Be prepared to answer questions about your symptoms and your health history. Questions may include:
© 2026 Mayo Foundation for Medical Education and Research. All rights reserved. Terms of Use